The activation of STAT5 in breast cancer cells could also inhibit their migratory and invasive potential through the downregulation of matrix metalloproteases (MMP) 2 and 9, while upregulating E-cadherin expression on the cell surface [53]. The gene discussed is STAT5A; the disease is breast carcinoma.